Travere Therapeutics TVTX
NASDAQ TVTX
$58.88 -1.11 (-1.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Short term Debt (2018 - 2025)

Updated

Travere Therapeutics' Short term Debt came in at $68.84 million for Q2 2025, up 0.1% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Short term Debt (2018 - 2025) Analysis & Trends

At the end of FY2024, Travere Therapeutics' Short term Debt was $68.68 million.

  • The Q2 2025 figure represents the highest quarterly Short term Debt in data going back to Q2 2018.
  • Business Quant data shows TVTX's Short term Debt at $68.76 million (Q1 2025), $68.68 million (Q4 2024) and $68.6 million (Q3 2024) in the three quarters before Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Travere Therapeutics 5.55 Bn 5.14 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 68.84 Mn
Mar 31, 2025 68.76 Mn
Dec 31, 2024 68.68 Mn
Sep 30, 2024 68.60 Mn
Mar 31, 2019 22.54 Mn
Dec 31, 2018 22.46 Mn
Sep 30, 2018 22.38 Mn
Jun 30, 2018 45.40 Mn
API Access

Travere Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=TVTX&period=max&api_key=YOUR_API_KEY